The Drug Retail industry on FinBizNet covers 1 listed company, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 1 |
|---|---|
| Combined market cap | ₹7,386 Cr |
| Median P/E (profitable companies) | 34.2 |
| Median return on equity | 11.8% |
| Companies with latest quarterly results | 1 of 1 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Medplus Health Services Limited | ₹7,386 Cr | 34.2 | 11.8% | ₹2,037 Cr | ₹56 Cr | Q2 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 1 listed company in the Drug Retail industry: Medplus Health Services Limited.
By market capitalisation, the largest Drug Retail companies are Medplus Health Services Limited (₹7,386 Cr).
The 1 Drug Retail companies tracked on FinBizNet have a combined market capitalisation of about ₹7,386 Cr.
The median price-to-earnings ratio across 1 profitable Drug Retail companies is 34.2, and the median return on equity across the industry is 11.8%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Drug Retail industry.